Copper Peptides in Hair Care: What GHK-Cu Does, and What It Doesn't

GHK-Cu is the copper peptide with the strongest hair-specific evidence, and all of it is laboratory work: follicle elongation in culture, more dermal papilla cell proliferation, less cell death. No controlled human trial has shown a peptide regrows hair, so treat it as a supporting step, not a treatment.

Copper peptides are the most overclaimed ingredient in hair care right now. The products promise regrowth, and the evidence stops at the lab bench. The lab evidence is real, and it is worth describing, but the regrowth claim is not backed by a human trial, and the post says so plainly.

GHK-Cu is the peptide with the strongest hair-specific evidence. It is a tripeptide, glycyl-histidyl-lysine, bound to a copper ion, and it is naturally present in human plasma. The question is what it does to hair, and the answer depends on whether you ask a petri dish or a person.

The lab evidence

Pyo and colleagues, 2007, in Archives of Pharmacal Research, tested AHK-Cu, a close relative, on human hair follicles in culture. At concentrations from 10 to the minus 12 to 10 to the minus 9 molar, it stimulated follicle elongation and dermal papilla cell proliferation. Caspase-3, a marker of cell death, fell 42.7 percent. PARP, another cell-death marker, fell 77.5 percent.

GHK-Cu raises VEGF, the growth factor that builds blood vessels around the follicle, and lowers TGF-beta1, the signal that pushes follicles from growth into regression. It acts on the Wnt and beta-catenin pathway, the same pathway that controls the hair cycle. The mechanism is coherent, and it is all in the laboratory.

The one human trial, and its limits

Lee and colleagues, 2016, in the Annals of Dermatology, ran the only randomized, double-blind, placebo-controlled trial: 45 men, GHK combined with 5-ALA, six months. The 50 milligram per milliliter group gained 71.5 hairs per square centimeter, against 9.6 in the placebo group. That is a real gain, and it is the best human number peptides have.

The limits are the story. The treatment combined GHK with 5-ALA, not GHK-Cu alone, so the trial cannot say what the peptide did by itself. The lower dose beat the higher dose, which is not the pattern a clean dose-response would show. And no peptide holds FDA approval for hair loss, which is the regulator's way of saying the human evidence is not there yet.

Where it fits

A supporting step alongside minoxidil or finasteride, not a replacement. Minoxidil 5 percent has decades of randomized trials behind it. Copper peptides have one small combination trial and a strong lab record. The two are not in the same league, and a product that presents them as alternatives is overselling the peptide.

Copper ions alone inhibited type 1 5-alpha reductase up to 90 percent in a dish, which is sometimes quoted as evidence that peptides block DHT. A dish is not a scalp, and GHK-Cu is not copper ions. If a product promises regrowth from peptides alone, the trial record does not back it.

Frequently asked questions

What are copper peptides for hair?

Copper peptides, mainly GHK-Cu, are small protein fragments bound to a copper ion. In laboratory culture they lengthen human hair follicles, stimulate dermal papilla cells, and reduce cell-death markers. No controlled human trial has shown a peptide regrows hair on its own.

Do copper peptides regrow hair?

There is no controlled human trial showing a peptide regrows hair. The only randomized trial combined GHK with 5-ALA, and the 50 milligram per milliliter group gained 71.5 hairs per square centimeter against 9.6 for placebo. The trial cannot say what the peptide did by itself.

Are copper peptides better than minoxidil?

No. Minoxidil 5 percent has decades of randomized trials behind it. Copper peptides have one small combination trial and a strong laboratory record. Treat peptides as a supporting step alongside a proven treatment, not as a replacement.

Are copper peptides safe?

GHK-Cu is naturally present in human plasma and is generally well tolerated on skin. The safety record is good, but the efficacy record is thin. The risk is not side effects. It is spending money on a product that has not been shown to regrow hair.